B
ARKG icon

Bellecapital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bellecapital’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
+5,031
New +$160K 0.03% 97
2025
Q4 		– Sell
-16,065
Closed -$446K – 131
2025
Q3 		$446K Sell
16,065
-13,659
-46% -$345K 0.07% 78
2025
Q2 		$724K Sell
29,724
-8,267
-22% -$181K 0.13% 66
2025
Q1 		$789K Sell
37,991
-272
-0.7% -$6.83K 0.16% 64
2024
Q4 		$901K Sell
38,263
-35,320
-48% -$869K 0.16% 63
2024
Q3 		$1.88M Sell
73,583
-1,250
-2% -$31.8K 0.37% 46
2024
Q2 		$1.76M Buy
74,833
+10,100
+16% +$255K 0.37% 47
2024
Q1 		$1.86M Buy
64,733
+3,091
+5% +$93K 0.41% 47
2023
Q4 		$2.02M Sell
61,642
-11,889
-16% -$323K 0.46% 47
2023
Q3 		$2.05M Buy
73,531
+1,084
+1% +$35.4K 0.51% 46
2023
Q2 		$2.47M Buy
72,447
+8,724
+14% +$274K 0.6% 45
2023
Q1 		$1.92M Buy
63,723
+5,380
+9% +$167K 0.48% 46
2022
Q4 		$1.65M Sell
58,343
-17,192
-23% -$546K 0.46% 46
2022
Q3 		$2.48M Buy
75,535
+3,981
+6% +$146K 0.76% 37
2022
Q2 		$2.25M Sell
71,554
-17,312
-19% -$605K 0.63% 44
2022
Q1 		$4.08M Buy
88,866
+13,961
+19% +$666K 1.29% 23
2021
Q4 		$4.59M Buy
74,905
+321
+0.4% +$22.2K 1.31% 24
2021
Q3 		$5.57M Buy
74,584
+6,876
+10% +$577K 1.7% 19
2021
Q2 		$6.26M Sell
67,708
-7,303
-10% -$621K 1.9% 16
2021
Q1 		$6.66M Sell
75,011
-15,506
-17% -$1.54M 2.08% 15
2020
Q4 		$8.44M Buy
+90,517
New +$7.21M 2.82% 5

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bellecapital's ARKG Position: Q2 2026 in Review

Bellecapital opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 5,031 shares worth $212K. The stake represents 0.03% of the portfolio and ranks #97 among its holdings. This is a return to the name: Bellecapital previously reported a position in ARKG as recently as Q3 2025.

Bellecapital first reported a position in ARKG in Q4 2020 and has held it in 21 quarters since. The position peaked at $8.44M in Q4 2020. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Bellecapital held 5,031 shares of ARK Genomic Revolution ETF worth $212K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Bellecapital position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.03% of Bellecapital's portfolio in Q2 2026, its #97 holding.
  • Bellecapital first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 21 quarters since.
  • Bellecapital's ARK Genomic Revolution ETF position peaked at $8.44M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.